BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 30389552)

  • 1. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.
    Metwally M; Bayoumi A; Romero-Gomez M; Thabet K; John M; Adams LA; Huo X; Aller R; García-Monzón C; Teresa Arias-Loste M; Bugianesi E; Miele L; Gallego-Durán R; Fischer J; Berg T; Liddle C; Qiao L; George J; Eslam M
    J Hepatol; 2019 Mar; 70(3):494-500. PubMed ID: 30389552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Gao F; Zheng KI; Zhu PW; Li YY; Ma HL; Li G; Tang LJ; Rios RS; Liu WY; Pan XY; Targher G; Byrne CD; Chen YP; Zheng MH
    Br J Nutr; 2021 Sep; 126(6):813-824. PubMed ID: 33198849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD
    Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
    Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver.
    Canivet CM; Bonnafous S; Rousseau D; Leclere PS; Lacas-Gervais S; Patouraux S; Sans A; Luci C; Bailly-Maitre B; Iannelli A; Tran A; Anty R; Gual P
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165705. PubMed ID: 32001301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
    Stättermayer AF; Traussnigg S; Aigner E; Kienbacher C; Huber-Schönauer U; Steindl-Munda P; Stadlmayr A; Wrba F; Trauner M; Datz C; Ferenci P
    J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
    Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
    Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men.
    Brondani LA; Boelter G; Assmann TS; Leitão CB; Canani LH; Crispim D
    Metabolism; 2015 Sep; 64(9):952-7. PubMed ID: 26024756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RS3480 Polymorphism of
    Canto-Cetina T; Silva-Nicanor D; Coral-Vázquez RM; Cano-Martínez LJ; Canto P
    Metab Syndr Relat Disord; 2023 Nov; 21(9):503-508. PubMed ID: 37566466
    [No Abstract]   [Full Text] [Related]  

  • 10. SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects.
    Al-Daghri NM; Mohammed AK; Al-Attas OS; Amer OE; Clerici M; Alenad A; Alokail MS
    Lipids Health Dis; 2016 Mar; 15():54. PubMed ID: 26968837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.
    Xu M; Li Y; Zhang S; Wang X; Shen J; Zhang S
    Ann Hepatol; 2019; 18(3):456-460. PubMed ID: 31054977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and its Association with Irisin Level Among Individuals with FNDC5/Irisin Gene Variants RS16835198 and RS726344.
    Abdu Allah AM; Hammoudah SA; Abd El Gayed EM; El-Attar LM; Shehab-Eldin WA
    Protein Pept Lett; 2018; 25(6):560-569. PubMed ID: 29745314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
    Petta S; Maida M; Grimaudo S; Pipitone RM; Macaluso FS; Cabibi D; Cammà C; Di Marco V; Sferrazza S; Craxì A
    Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin ameliorates age-associated sarcopenia and metabolic dysfunction.
    Guo M; Yao J; Li J; Zhang J; Wang D; Zuo H; Zhang Y; Xu B; Zhong Y; Shen F; Lu J; Ding S; Hu C; Xu L; Xiao J; Ma X
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):391-405. PubMed ID: 36510115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation.
    Míková I; Neřoldová M; Hubáček JA; Dlouhá D; Jirsa M; Honsová E; Sticová E; Lánská V; Špičák J; Trunečka P
    Transplantation; 2020 Mar; 104(3):526-534. PubMed ID: 31356578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels.
    Tanisawa K; Taniguchi H; Sun X; Ito T; Cao ZB; Sakamoto S; Higuchi M
    Metabolism; 2014 Apr; 63(4):574-83. PubMed ID: 24559842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common single nucleotide polymorphisms in the FNDC5 gene and serum irisin levels in acute myocardial infarction.
    Önalan Etem E; Diş Ö; Tektemur A; Korkmaz H; Buran Kavuran İ
    Anatol J Cardiol; 2021 Aug; 25(8):528-535. PubMed ID: 34369880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.